Effects of PCSK9 Inhibition by Evolocumab on Postprandial Lipid Metabolism in Type 2 Diabetes
Clinical trial NCT02948777 · COMPLETED
Trial details
- NCT number
- NCT02948777
- Sponsor
- Marja-Riitta Taskinen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-06-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.